You have 9 free searches left this month | for more free features.

SRSF2

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

Recruiting
  • Metastatic Solid Tumor
  • +4 more
  • Recommendation for treatment with immunotherapy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 8, 2022

SRSF2 Gene Mutation in Patients With t-MDS/AML

Completed
  • Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
  • PCR and cytogenetics
  • Assiut, Egypt
  • +1 more
May 17, 2020

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Tampa, Florida
  • +8 more
Apr 5, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Epigenetic Age on Clinic-biological Presentation and Prognosis

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Assessment of the epigenetic age
  • Bordeaux, France
    CHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023

Clonal Hematopoiesis of Indeterminate Potential in Venous

Active, not recruiting
  • Venous Thromboembolism
    • Nîmes, France
      CHU de Nimes
    Jan 24, 2022

    Next Generation Sequencing in Familial Acute Myeloid Leukemia

    Recruiting
    • Leukemia
    • Analysis with molecular biology
    • Brescia, Italy
      Chair of Hematology and Bone marrow Transplant Unit
    Apr 21, 2022

    Myocardial Infarction Trial in Pessac (Specific blood sampling)

    Completed
    • Myocardial Infarction
    • Specific blood sampling
    • Pessac, France
      Bordeaux University Hospital
    Feb 21, 2022

    Diagnostic Platform to Perform Centralized and Standardized

    Completed
    • Acute Myeloid Leukemia
    • NGS techniques
    • Córdoba, Spain
    • +6 more
    Feb 15, 2021

    MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

    Recruiting
    • Myelodysplastic Syndromes
    • Next Generation Sequencing
    • +5 more
    • Innsbruck, Tyrol, Austria
      Medical University of Innsbruck
    Apr 6, 2022

    Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Amiens, France
    • +29 more
    Apr 8, 2022

    GENOMED4ALL: Improving MDS Classification and Prognosis by AI

    Active, not recruiting
    • Myelodysplastic Syndromes
      • Milano, Italy
        Istituto Clinico Humanitas
      Jun 28, 2021

      MDS Patients Using Sequential Peripheral Blood Samples

      Recruiting
      • Myelodysplastic Syndromes
        • Badalona, Barcelona, Spain
          Josep Carreras Leukaemia Research Institute
        Mar 8, 2022

        MDS Trial in Hong Kong

        Recruiting
        • Myelodysplastic Syndromes
          • Hong Kong, Hong Kong
            Department of Medicine, the University of Hong Kong, Queen Mary
          Nov 3, 2020

          Lung Cancer Trial in La Tronche (Blood and respiratory fluids sampling, Biopsy, Excised tissues)

          Completed
          • Lung Cancer
          • Blood and respiratory fluids sampling
          • +2 more
          • La Tronche, France
            UniversityHospitalGrenoble
          Mar 17, 2020

          Myeloproliferative Tumors Trial in Taoyuan

          Enrolling by invitation
          • Myeloproliferative Neoplasms
            • Taoyuan, State, Taiwan
              Chang Gung Memorial Hospital-Linkou
            Aug 4, 2021

            Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

            Completed
            • Primary Myelofibrosis
            • +2 more
            • Rochester, Minnesota
              (unnamed)
            Aug 24, 2021

            Molecular Defects in Idiopathic Cytopenia of Undetermined

            Unknown status
            • Myelodysplastic Syndromes
            • ICUS
            • Amiens, France
              CHU Amiens
            Aug 2, 2018

            Aging of Hematopoietic Stem Cells - Molecular Architecture of

            Completed
            • Anemia
            • Clonal Hematopoiesis
            • targeted genome sequencing
            • Rozzano, Milano, Italy
              Istituto Clinico Humanitas
            Apr 19, 2019

            MDS Trial in Paris (blood samples)

            Completed
            • Myelodysplastic Syndromes
            • blood samples
            • Paris, France
              Assistance publique-Hôpitaux de Paris, Hôpital Cochin
            Mar 16, 2018

            Chronic Myelomonocytic Leukemia Trial in Nice

            Unknown status
            • Chronic Myelomonocytic Leukemia
              • Nice, France
                CHU de Nice
              Mar 16, 2018

              Patients With Myelodysplastic Syndrome

              Completed
              • Myelodysplastic Syndrome
              • spliceosome
              • Seoul, Korea, Republic of
                Samsung Medical Center
              Feb 11, 2014